Figure 2.

Pipeline designed for data analysis. Bioinformatic analysis including mapping, calling, filtering, and annotation of variants, followed by a pathogenicity analysis in which the candidate variants (CV) are prioritized and validated with the aim of finding the causal mutation and inform the patient. A reanalysis of regions with low coverage and WES will be conducted when no candidate variants (NCV) are identified.